Developer docs
API playgroundTry for free, no card

Search company profiles

Microvi Biotechnologies

Full company profile

uuid00027no

Namestring
Microvi Biotechnologies
Legal namestring
Microvi Biotech
Websiteurl
microvi.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Microvi Biotechnologies is a private Hayward, California-based applied biotechnology company that develops, manufactures, and commercializes biocatalytic technologies built around its proprietary MNE™ (MicroNiche Engineering) encapsulation platform. The platform encapsulates microbial strains in a protective, high-density biological matrix, converting fragile biology into modular, drop-in industrial systems that integrate directly into existing reactors and become operational within days. Microvi holds 50+ patents and trade secrets protecting the platform, which has been independently validated at scale by Lawrence Berkeley National Laboratory for biomanufacturing applications.

The company sells its biosolutions as a permanent, living layer of industrial infrastructure across five verticals: Water & Wastewater (nitrogen removal, nutrient recovery, hexavalent chromium reduction below 5 ppb), Industrial Bioprocessing (higher-yield, lower-energy fermentation), Agriculture (biological fertilizer efficiency and nitrogen cycle optimization), Climate & Remediation (GHG reduction, PFAS degradation, circular resource recovery), and Energy & Resource Recovery (biological energy generation, nutrient recovery). The platform claims 5–10× smaller system footprint, 10× reduction in chemical consumption, ~50% lower energy use, and ~50% total cost savings versus conventional approaches. Microvi operates commercial plants in the United States and United Kingdom and reports 45+ global deployments.

Microvi operates an enterprise field sales model, with direct engagement with industrial operators and a recurring subscription revenue model for biosolutions. The company has raised approximately $8.87M across disclosed funding events from 2009 to 2025, with notable capital sources including NIH grants ($2.2M+ across 2021 and 2022), SKion (2015), Elemental Impact (2018), and The 22 Fund (2025), alongside a $5M equity round in 2014. The leadership team is led by founder Fatemeh Shirazi, PhD, who serves as CEO and CTO and personally holds 20 patents.

Short descriptiontext

Microvi Biotechnologies develops and commercializes its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, converting microbial organisms into modular, drop-in industrial biosolutions for water treatment, bioprocessing, agriculture, climate remediation, and energy applications across 45+ global deployments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHayward, United States
HQ citystring
Hayward
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biocatalytic technology, industrial biotechnology, biological water treatment, environmental remediation solutions, encapsulated microbial systems
Industry1 code
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code3 codes
  • Sewage Treatment Facilities221320
  • Chemical Manufacturing325
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
SIC code1 code
  • Industrial Organic Chemicals2860
Product category
Industrial Biotechnology
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biosolutions Products
TypeSubscription Recurring
Description

Microvi sells biosolutions, embedding biology as a permanent, living layer of industrial infrastructure. The company deploys its MNE™ technology platform as products/modules for water treatment, industrial bioprocessing, agriculture, climate remediation, and energy applications.

microvi.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1MNE™ (MicroNiche Engineering)
Description

Proprietary encapsulation technology that protects and structures living organisms — making them predictable, durable, and scalable across five critical industries including water, bioprocessing, agriculture, climate, and energy.

microvi.com
Core offering1 text field

Microvi develops, manufactures, and commercializes biocatalytic products based on its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, which protects and structures living microbial organisms so they can be deployed as durable industrial systems. These biosolutions are applied across five verticals — water and wastewater treatment, industrial bioprocessing, agriculture, climate and environmental remediation, and energy and resource recovery — as modular, drop-in modules that integrate into existing reactors and infrastructure.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 5–10× smaller system footprint versus conventional treatment
+5 more records
Product overview1 text field

Microvi Biotechnologies offers a unified platform-plus-application architecture centered on its proprietary MNE™ (MicroNiche Engineering) platform. This core technology is an encapsulation system that protects and structures living organisms for industrial use. The platform is applied across multiple industry verticals through specialized application modules: Water & Wastewater Solutions (nitrogen removal, nutrient recovery), Industrial Bioprocessing Solutions (fermentation and chemical production), Agriculture Solutions (fertilizer efficiency, nitrogen optimization), Climate & Remediation Solutions (GHG reduction, PFAS degradation), and Energy & Resource Recovery Solutions (biological energy generation, nutrient recovery from waste).

Product and service4 records
1MNE™ (MicroNiche Engineering) Platform
CategoryCore platform / proprietary technology
Description

A proprietary encapsulation technology that creates a protective, high-density biological matrix with controlled mass transfer, converting fragile microbial strains into predictable, durable, and scalable industrial systems for enterprise customers.

2Water & Wastewater Solutions
CategoryApplication module — water treatment
Description

Biological systems for nitrogen removal, nutrient recovery, and regulatory compliance (including hexavalent chromium reduction to less than 5 ppb) in water and wastewater treatment facilities.

3Industrial Bioprocessing Solutions
CategoryApplication module — industrial bioprocessing
Description

Biological catalysts for fermentation and chemical production offering higher yield, faster cycles, and lower energy consumption for industrial bioprocessing operators.

4Agriculture Solutions
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lawrence Berkeley National Laboratory independently validated the MNE™ technology at scale for biomanufacturing applications, providing scientific credibility and third-party verification of the platform's effectiveness.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Water treatment systems integrator offering biological and membrane-based solutions to municipal and industrial customers. Comparable in target market and customer type to Microvi's water & wastewater segment.

TypeBroad incumbent
Description

Global leader in industrial enzymes and microbial solutions, directly comparable to Microvi's industrial biotechnology platform. Operates across similar end-markets (water, agriculture, bioenergy) but at vastly greater scale and with established customer relationships.

TypeRegional player
Description

Water and wastewater treatment technology provider with biological treatment solutions. Comparable in technology category to Microvi's MNE™ modules, though serving primarily European industrial water markets.

TypeDirect peer
Description

Biological wastewater treatment company serving industrial and municipal customers with microbial solutions. Comparable in size and approach to Microvi's water & wastewater segment.

5Veolia Water Technologies
TypeBroad incumbent
Description

Dominant water treatment incumbent with full-service offerings including biological treatment. While not exclusively biotech-focused, Veolia competes for the same ~300,000 facilities Microvi targets in the Water & Wastewater vertical.

TypeBroad incumbent
Description

Global ingredient and biotechnology company with industrial biotech offerings spanning agriculture, food, and sustainability. Comparable to Microvi's microbial-based platform across agriculture and bioprocessing verticals at far greater scale.

TypeDirect peer
Description

Environmental biotechnology company applying biological systems to agricultural waste treatment and nutrient recovery. Comparable to Microvi's agriculture and climate/remediation verticals with similar biological infrastructure approach.

TypeBroad incumbent
Description

Major water treatment company offering biological treatment systems for municipal and industrial customers. Competes with Microvi's MNE™ modules in the wastewater treatment vertical with broader portfolio offerings.

TypeDirect peer
Description

Direct competitor using biological systems for industrial wastewater treatment and resource recovery. Targets overlapping water and industrial biotech customers with similar bio-based treatment solutions.

TypeDirect peer
Description

Water treatment technology company using biological and advanced processes for industrial water applications. Comparable in scale and target market to Microvi's water vertical with similar customer profile.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Microvi Biotechnologies

Industrial Biotechnologymicrovi.com

Microvi Biotechnologies develops and commercializes its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, converting microbial organisms into modular, drop-in industrial biosolutions for water treatment, bioprocessing, agriculture, climate remediation, and energy applications across 45+ global deployments.

What Microvi Biotechnologies does

Microvi Biotechnologies is a private Hayward, California-based applied biotechnology company that develops, manufactures, and commercializes biocatalytic technologies built around its proprietary MNE™ (MicroNiche Engineering) encapsulation platform. The platform encapsulates microbial strains in a protective, high-density biological matrix, converting fragile biology into modular, drop-in industrial systems that integrate directly into existing reactors and become operational within days. Microvi holds 50+ patents and trade secrets protecting the platform, which has been independently validated at scale by Lawrence Berkeley National Laboratory for biomanufacturing applications.

The company sells its biosolutions as a permanent, living layer of industrial infrastructure across five verticals: Water & Wastewater (nitrogen removal, nutrient recovery, hexavalent chromium reduction below 5 ppb), Industrial Bioprocessing (higher-yield, lower-energy fermentation), Agriculture (biological fertilizer efficiency and nitrogen cycle optimization), Climate & Remediation (GHG reduction, PFAS degradation, circular resource recovery), and Energy & Resource Recovery (biological energy generation, nutrient recovery). The platform claims 5–10× smaller system footprint, 10× reduction in chemical consumption, ~50% lower energy use, and ~50% total cost savings versus conventional approaches. Microvi operates commercial plants in the United States and United Kingdom and reports 45+ global deployments.

Microvi operates an enterprise field sales model, with direct engagement with industrial operators and a recurring subscription revenue model for biosolutions. The company has raised approximately $8.87M across disclosed funding events from 2009 to 2025, with notable capital sources including NIH grants ($2.2M+ across 2021 and 2022), SKion (2015), Elemental Impact (2018), and The 22 Fund (2025), alongside a $5M equity round in 2014. The leadership team is led by founder Fatemeh Shirazi, PhD, who serves as CEO and CTO and personally holds 20 patents.

Microvi Biotechnologies firmographics

Firmographics
Name
Microvi Biotechnologies
Legal name
Microvi Biotech
Website
https://microvi.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Microvi Biotechnologies develops and commercializes its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, converting microbial organisms into modular, drop-in industrial biosolutions for water treatment, bioprocessing, agriculture, climate remediation, and energy applications across 45+ global deployments.
Ownership category
akta.pro rank

Microvi Biotechnologies industry classification

Industry
Product category
Industrial Biotechnology
NAICS
Sewage Treatment Facilities (221320), Chemical Manufacturing (325), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
SIC
Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Biocatalytic technology
  • Industrial biotechnology
  • Biological water treatment
  • Environmental remediation solutions
  • Encapsulated microbial systems

Where Microvi Biotechnologies is headquartered

Location

Headquarters

HQ city
Hayward
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Microvi Biotechnologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Biosolutions Products: Microvi sells biosolutions, embedding biology as a permanent, living layer of industrial infrastructure. The company deploys its MNE™ technology platform as products/modules for water treatment, industrial bioprocessing, agriculture, climate remediation, and energy applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Microvi Biotechnologies product offering

Product offering

Core offering

Microvi develops, manufactures, and commercializes biocatalytic products based on its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, which protects and structures living microbial organisms so they can be deployed as durable industrial systems. These biosolutions are applied across five verticals — water and wastewater treatment, industrial bioprocessing, agriculture, climate and environmental remediation, and energy and resource recovery — as modular, drop-in modules that integrate into existing reactors and infrastructure.

Product overview

Microvi Biotechnologies offers a unified platform-plus-application architecture centered on its proprietary MNE™ (MicroNiche Engineering) platform. This core technology is an encapsulation system that protects and structures living organisms for industrial use. The platform is applied across multiple industry verticals through specialized application modules: Water & Wastewater Solutions (nitrogen removal, nutrient recovery), Industrial Bioprocessing Solutions (fermentation and chemical production), Agriculture Solutions (fertilizer efficiency, nitrogen optimization), Climate & Remediation Solutions (GHG reduction, PFAS degradation), and Energy & Resource Recovery Solutions (biological energy generation, nutrient recovery from waste).

Differentiator

Problem solved

Functional benefit

Brands

  • MNE™ (MicroNiche Engineering): Proprietary encapsulation technology that protects and structures living organisms — making them predictable, durable, and scalable across five critical industries including water, bioprocessing, agriculture, climate, and energy.

Products and services

  • MNE™ (MicroNiche Engineering) Platform A proprietary encapsulation technology that creates a protective, high-density biological matrix with controlled mass transfer, converting fragile microbial strains into predictable, durable, and scalable industrial systems for enterprise customers.
  • Water & Wastewater Solutions Biological systems for nitrogen removal, nutrient recovery, and regulatory compliance (including hexavalent chromium reduction to less than 5 ppb) in water and wastewater treatment facilities.
  • Industrial Bioprocessing Solutions Biological catalysts for fermentation and chemical production offering higher yield, faster cycles, and lower energy consumption for industrial bioprocessing operators.
  • Agriculture Solutions

Quantifiable outcome

  • 5–10× smaller system footprint versus conventional treatment
  • +5 more outcomes

Companies that use Microvi Biotechnologies

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Microvi Biotechnologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Microvi Biotechnologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Lawrence Berkeley National LaboratorycoreStrategic or Co-development PartnerLawrence Berkeley National Laboratory independently validated the MNE™ technology at scale for biomanufacturing applications, providing scientific credibility and third-party verification of the platform's effectiveness.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Microvi Biotechnologies competitors and assessment

Company assessment

Regional players

  • H2O Innovation: Water treatment systems integrator offering biological and membrane-based solutions to municipal and industrial customers. Comparable in target market and customer type to Microvi's water & wastewater segment.
  • Aqseptence Group: Water and wastewater treatment technology provider with biological treatment solutions. Comparable in technology category to Microvi's MNE™ modules, though serving primarily European industrial water markets.

Broad incumbents

  • Novozymes: Global leader in industrial enzymes and microbial solutions, directly comparable to Microvi's industrial biotechnology platform. Operates across similar end-markets (water, agriculture, bioenergy) but at vastly greater scale and with established customer relationships.
  • Veolia Water Technologies: Dominant water treatment incumbent with full-service offerings including biological treatment. While not exclusively biotech-focused, Veolia competes for the same ~300,000 facilities Microvi targets in the Water & Wastewater vertical.
  • DSM-Firmenich: Global ingredient and biotechnology company with industrial biotech offerings spanning agriculture, food, and sustainability. Comparable to Microvi's microbial-based platform across agriculture and bioprocessing verticals at far greater scale.
  • Evoqua Water Technologies: Major water treatment company offering biological treatment systems for municipal and industrial customers. Competes with Microvi's MNE™ modules in the wastewater treatment vertical with broader portfolio offerings.

Direct peers

  • Organica Biotech: Biological wastewater treatment company serving industrial and municipal customers with microbial solutions. Comparable in size and approach to Microvi's water & wastewater segment.
  • Bion Environmental Technologies: Environmental biotechnology company applying biological systems to agricultural waste treatment and nutrient recovery. Comparable to Microvi's agriculture and climate/remediation verticals with similar biological infrastructure approach.
  • Cambrian Innovation: Direct competitor using biological systems for industrial wastewater treatment and resource recovery. Targets overlapping water and industrial biotech customers with similar bio-based treatment solutions.
  • Clean TeQ Water: Water treatment technology company using biological and advanced processes for industrial water applications. Comparable in scale and target market to Microvi's water vertical with similar customer profile.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Microvi Biotechnologies social profiles

Digital presence

Microvi Biotechnologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Microvi Biotechnologies leadership team

Management profile

Number of profiles

Profiles1 record

Microvi Biotechnologies funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Microvi Biotechnologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microvi Biotechnologies

What does Microvi Biotechnologies do?

Microvi develops, manufactures, and commercializes biocatalytic products based on its proprietary MNE™ (MicroNiche Engineering) encapsulation platform, which protects and structures living microbial organisms so they can be deployed as durable industrial systems. These biosolutions are applied across five verticals — water and wastewater treatment, industrial bioprocessing, agriculture, climate and environmental remediation, and energy and resource recovery — as modular, drop-in modules that integrate into existing reactors and infrastructure.

Is Microvi Biotechnologies a public or private company?

Microvi Biotechnologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Microvi Biotechnologies founded?

Microvi Biotechnologies was founded in 2010. It employs 11 to 50 people.

Where is Microvi Biotechnologies based?

Microvi Biotechnologies is headquartered in Hayward, United States, in the North America region.

How does Microvi Biotechnologies make money?

One revenue line is on record: biosolutions Products.

Who are Microvi Biotechnologies's main competitors?

Regional players on record are H2O Innovation and Aqseptence Group. Broad incumbents are Novozymes, Veolia Water Technologies, DSM-Firmenich and Evoqua Water Technologies. Direct peers are Organica Biotech, Bion Environmental Technologies, Cambrian Innovation and Clean TeQ Water.

Does Microvi Biotechnologies have an API?

No public API is recorded for Microvi Biotechnologies.

What industry is Microvi Biotechnologies in?

Microvi Biotechnologies's product category is Industrial Biotechnology. Its primary akta.pro industry code is EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its NAICS code is 221320 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CranfieldNew biotechnology to remove phosphorus from wastewater given funding boostCranfield University and US-based biotechnology company Microvi have secured funding from OFWAT to commercialize their bio-mineral phosphorus removal (BMPR) technology for wastewater treatment. The process utilizes engineered bacteria to remove phosphorus without metal coagulants, achieving a 96% removal rate in initial tests while recovering nutrients as reusable salts. This development aims to reduce costs and environmental impacts for the water sector by offering a sustainable alternative to traditional chemical treatments.PR NewswireMicrovi's Commercial Plant Brings Millions of Gallons of Clean Water to ArizonaMicrovi and the City of Goodyear launched Arizona's first groundwater biological nitrate treatment system, with operations beginning in Fall 2022. The commercial plant using Microvi's MNE™ technology consistently treats nitrate in groundwater to concentrations below 3 mg/L, exceeding drinking water quality standards while operating with no secondary waste stream. This marks Microvi's second commercial deployment following one in California, positioning the company as an emerging player in water treatment innovation.BioSpaceMicrovi Awarded Over $1.1 Million to Scale its New Technology that Eliminates a Cancer-causing Chemical in WaterMicrovi Biotech has been awarded over $1.1 million in funding from the National Institute of Health (NIH) to scale up its technology that eliminates chromium in drinking water. This funding will support advancements that could impact millions by reducing cancer risks associated with chromium pollution and aims to meet both current and proposed future regulatory limits for the chemical. The technology has already shown success in reducing hexavalent chromium levels significantly, demonstrating the company's commitment to improving water quality.MicroviMicrovi Awarded Over $1.1 Million to Scale its New Technology that Eliminates a Cancer-causing Chemical in Water — MicroviMicrovi announced it has been awarded over $1.1 million in funding from the National Institute of Health (NIH) to scale its technology for eliminating hexavalent chromium from drinking water. The company's MicroNiche Engineering platform successfully reduces chromium levels below 5 ppb, meeting current and potential future regulatory standards while offering significant cost savings compared to conventional methods.PR NewswireMicrovi Awarded Over $1.1 Million to Scale its New Technology that Eliminates a Cancer-causing Chemical in WaterMicrovi has been awarded over $1.1 million in funding from the National Institute of Health to scale its technology for eliminating hexavalent chromium from drinking water. The company's MicroNiche Engineering platform successfully reduced chromium levels below 5 ppb, meeting current and potential future regulatory standards while offering cost savings compared to conventional approaches.PR NewswireMicrovi Awarded Arizona's First Commercial Biological Nitrate Treatment Plant by the City of GoodyearMicrovi, a biotechnology company based in the San Francisco Bay Area, was awarded a contract by the City of Goodyear, Arizona for a commercial groundwater nitrate treatment plant, marking the first commercial biological nitrate treatment in the state and Microvi's first installation in Arizona. The plant, scheduled for summer 2022 commissioning, will utilize Microvi's MicroNiche Engineering technology to reduce nitrate levels below the Maximum Contaminant Limit without producing a significant waste stream. The project represents a milestone for Microvi as it expands into new states facing drinking water challenges from drought and population growth.PR NewswireWessex Water Evaluates Microvi MNE for Ammonia and Nitrate Removal to Support AMP7 StrategyWessex Water and Microvi announced a collaboration evaluating Microvi's MicroNiche Engineering (MNE) treatment process for ammonia and nitrogen removal from wastewater to support Wessex Water's AMP7 project implementation. A demonstration plant has been operating at a Wessex Water treatment facility in Southwest England since March 2021, with initial testing showing the process is robust and reliable for tertiary ammonia removal, while nitrate reduction testing is planned for summer months. Both companies characterized the collaboration positively, with Wessex Water noting the technology's simplicity to operate and maintain.PR NewswireMicrovi Restores Critical Community Drinking Water for the City of San Juan BautistaMicrovi announced the installation of its MNE nitrate treatment system for the City of San Juan Bautista, California, to address high nitrate levels in local water sources. The project aims to provide a cost-effective solution for the community's drinking water supply and is partially funded through Microvi's partnership with climate-tech nonprofit Elemental Excelerator.PR NewswireMicrovi and FLI Water Announce Strategic Partnership in the United Kingdom and IrelandMicrovi and FLI Water have formed an exclusive strategic partnership to expand their collaboration across the United Kingdom and Ireland for industrial and municipal wastewater projects. The agreement enables FLI to offer Microvi's MicroNiche Engineering (MNE) biological treatment technologies as turnkey solutions to water utilities. The partnership builds on prior collaboration, including successful demonstration units deployed with major UK water utilities such as Thames Water, Scottish Water, Wessex Water, and Southern Water.PR NewswireMicrovi Commissions First Commercial Sidestream Treatment System in the U.S. Pacific Coast Region at Oro Loma/Castro Valley Sanitary Districts' 12 MGD PlantMicrovi and Oro Loma/Castro Valley Sanitary Districts commissioned the first commercial sidestream treatment system in the U.S. Pacific Coast Region at a 12 MGD plant in San Lorenzo, California. The system uses Microvi's MNE technology to reduce nitrogen discharge to the San Francisco Bay by up to 400,000 pounds per year, achieving 25% energy savings and 40% carbon dosing reduction. The project, funded by the EPA and OLSD/CVSan, is expected to reduce the nutrient load by 8,000,000 lbs over 20 years and includes a local internship program for workforce development.